THBS2/CA19-9 Detecting Pancreatic Ductal Adenocarcinoma at Diagnosis Underperforms in Prediagnostic Detection: Implications for Biomarker Advancement.

Udgata, Shirsa; Takenaka, Naomi; Bamlet, William R; Oberg, Ann L; Yee, Stephanie S; Carpenter, Erica L; Herman, Daniel; Kim, Jungsun; Petersen, Gloria M; Zaret, Kenneth S

Udgata, Shirsa; Takenaka, Naomi; Bamlet, William R; Oberg, Ann L; Yee, Stephanie S; Carpenter, Erica L; Herman, Daniel; Kim, Jungsun; Petersen, Gloria M; Zaret, Kenneth S.

Afiliação

Udgata S; Institute for Regenerative Medicine, Department of Cell and Developmental Biology, Abramson Cancer Center (Tumor Biology Program), Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Takenaka N; Institute for Regenerative Medicine, Department of Cell and Developmental Biology, Abramson Cancer Center (Tumor Biology Program), Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Bamlet WR; Department of Health Sciences Research, Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota.
Oberg AL; Department of Health Sciences Research, Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota.
Yee SS; Division of Hematology-Oncology, Department of Medicine, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Carpenter EL; Division of Hematology-Oncology, Department of Medicine, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Herman D; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Kim J; Institute for Regenerative Medicine, Department of Cell and Developmental Biology, Abramson Cancer Center (Tumor Biology Program), Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Petersen GM; Department of Health Sciences Research, Division of Epidemiology, Mayo Clinic, Rochester, Minnesota. zaret@upenn.edu.
Zaret KS; Institute for Regenerative Medicine, Department of Cell and Developmental Biology, Abramson Cancer Center (Tumor Biology Program), Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. zaret@upenn.edu.

Cancer Prev Res (Phila) ; 14(2): 223-232, 2021 02.

Article em En | MEDLINE | ID: mdl-33067248

Assuntos

Antígenos Glicosídicos Associados a Tumores/sangue; Biomarcadores Tumorais/sangue; Carcinoma Ductal Pancreático/diagnóstico; Neoplasias Pancreáticas/diagnóstico; Trombospondinas/sangue; Idoso; Carcinoma Ductal Pancreático/sangue; Estudos de Viabilidade; Feminino; Humanos; Masculino; Pessoa de Meia-Idade; Estadiamento de Neoplasias; Neoplasias Pancreáticas/sangue; Valor Preditivo dos Testes; Estudos Prospectivos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Antígenos Glicosídicos Associados a Tumores / Biomarcadores Tumorais / Trombospondinas / Carcinoma Ductal Pancreático Tipo de estudo: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Prev Res (Phila) Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google